Dawn Spiller is Senior Director & Group Manager, CMC Regulatory Affairs at AstraZeneca, Gaithersburg, MD, and a recognized leader in the strategic development and implementation of CMC regulatory strategies for biologic products including vaccines, biologic-device and bioconjugate products. With over two decades of experience in the pharmaceutical industry, Dawn has guided cross-functional teams through the complexities of biologics manufacturing, regulatory submissions, commercial launch, and global expansion. Dawn’s expertise spans the entire product lifecycle. A passionate advocate for continuous improvement and operational excellence, Dawn is committed to building high-performing teams and advancing regulatory science to bring innovative biologic therapies to patients.
Dawn Spiller
